Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer

Inactivation of Capicua (CIC) or upregulation of yes-associated protein 1, YAP1, leads to broad RAS-RAF-MEK-ERK inhibitor resistance and tumor progression in multiple human cancers. Despite these shared malignant phenotypes, it remains unclear whether CIC and YAP1 are mechanistically linked. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji Won, Luck, Cuyler, Wu, Wei, Ponce, Rovingaile Kriska, Lin, Yone Kawe, Gupta, Nehal, Okimoto, Ross A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674208/
https://www.ncbi.nlm.nih.gov/pubmed/36198276
http://dx.doi.org/10.1016/j.celrep.2022.111443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674208/
https://www.ncbi.nlm.nih.gov/pubmed/36198276
http://dx.doi.org/10.1016/j.celrep.2022.111443

Ejemplares similares